# AMILI Pte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amili-pte

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Website: www.amili.asia
- Total disclosed funding: $15M
- Latest round: Series A (Jul 1, 2022)
- Investors on record: 13

## About

Founded in 2019 and based in Singapore, AMILI Pte. Ltd. operates as a precision gut microbiome company. In July 2022, AMILI Pte. Ltd. raised USD 14.67 million in series A funding led by new investor Vulcan Capital, with participation from other new investors Blue7, Falcon House Partners, Fushia Investments, Rapzo Capital, Mojo Partners, Capital Code, Emtek Group, G. K. Goh Holdings, Pruksa Real Estate, Pureland Global Venture, SEEDS Capital, and TVM Capital Healthcare. The Series A funding valued AMILI at USD 35.26 million post-money.  

AMILI's services include services collection, analysis and processing of faecal microbiota transplants (FMTs); food for health advisory, the company partners with consumer companies to offer a full suite of gut microbiome-related services such as study design, sample collection, processing, microbiome sequencing, and subsequent bioinformatics analysis; and gut microbiome testing services which is offered through its direct-to-consumer precision gut health brand, BIO & ME. Also, the company has three core assets including a multi-ethnic Asia microbiome database; a microbiome bank with samples stored for metagenomic and metabolomic analysis; and AMILI PRIME, a proprietary analytics engine that helps develop diagnostics tests, predictive algorithms, and microbiome-modifying interventions. AMILI has established more than 20 research studies across a wide range of health indications. 

The company plans to use the 2022 funds raised to accelerate microbiome research partnerships and discovery, develop AMILI PRIME, and deepen AMILI’s presence in Southeast Asia initially and the rest of Asia subsequently.

## Funding rounds

- Series A, Jul 1, 2022, $15M — G. K. Goh Holdings, Vulcan, Pruksa Real Estate, Falcon House Partners, TVM Capital Healthcare, Fushia Investments, Mojo Partners, SEEDS Capital, Capital Code, Rapzo Capital, Emtek Group, Pureland Global Venture, Blue7

## Investors

- G. K. Goh Holdings — Series A
- Vulcan (https://capitalatlas.ai/funds/vulcan) — Series A
- Pruksa Real Estate — Series A
- Falcon House Partners (https://capitalatlas.ai/funds/falcon-house-partners) — Series A
- TVM Capital Healthcare (https://capitalatlas.ai/funds/tvm-capital-healthcare) — Series A
- Fushia Investments — Series A
- Mojo Partners — Series A
- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Series A
- Capital Code (https://capitalatlas.ai/funds/capital-code) — Series A
- Rapzo Capital — Series A
- Emtek Group — Series A
- Pureland Global Venture (https://capitalatlas.ai/funds/pureland-global-venture) — Series A
- Blue7 (https://capitalatlas.ai/funds/blue7) — Series A